http://www.onemedplace.com/blog/wp-content/uploads/2009/11/stomachache.jpg
The Cambridge, Mass.-based company has signed a $75 million deal with Astella Pharmaceuticals to market Ironwood's IBS drug in Asia.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/05/dollars.jpg
If the past week is any indication, big pharma is showing that it is willing to pay for biotech innovation.
View Article
More Pages to Explore .....
